SCHEMBL4906170

SCHEMBL4906170

NCCc1csc(-c2ccc(F)c(Cl)c2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.48
TP53 P04637 5/20 0.47
MAPT P10636 4/20 0.44
POLB P06746 3/20 0.43
LMNA P02545 5/20 0.43
RXFP1 Q9HBX9 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
EPHB4 P54760 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904228 0.87 TP53 (0.49) GFERTP53MAPTPOLBLMNA
SCHEMBL3371711 0.85 GFER (0.67) GFERTP53MAPTPOLBLMNA
SCHEMBL16398876 0.84 GFER (0.49) GFERTP53MAPTPOLBLMNA
SCHEMBL2224601 0.83 GFER (0.68) GFERTP53MAPTPOLBLMNA
SCHEMBL27740965 0.82 TP53 (0.43) GFERTP53MAPTPOLBLMNA
SCHEMBL2228478 0.80 LMNA (0.59) GFERTP53MAPTPOLBLMNA
SCHEMBL2662446 0.76 ABL1 (0.46) POLBEPHB4NPC1CYP3A4CYP2C9
SCHEMBL4900722 0.75 MAPT (0.53) MAPTPOLBLMNASMN1; SMN2ALDH1A1
SCHEMBL4906176 0.74 LMNA (0.57) GFERTP53MAPTPOLBLMNA
SCHEMBL4905756 0.74 LMNA (0.55) TP53MAPTPOLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101287718-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2008-10-15 CN disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD GFER 3520/4885TP53 3260/4885MAPT 1858/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD GFER 3619/4885TP53 3421/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD GFER 3619/4885TP53 3421/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.